2025 MeldRx Real World Test Plan

For Criteria §170.315 (g)(7), §170.315 (g)(10), and §170.315 (b)(10)


 

General Information

Plan Report ID Number:  RWT Plan_MeldRx_Darena_Solutions_10-28-2024

Developer Name: Darena Solutions LLC

Product Name(s): MeldRx

Version Number(s): 2

Certified Health IT: 15.04.04.1322.Blue.02.00.0.200807

Product List (CHPL) ID(s): 15.04.04.1322.Blue.02.00.0.200807

Developer Real World Testing Page URL: https://www.darenasolutions.com/meldrx-real-world-test-plan-2025


Justification for Real World Testing approach

Currently, the Certified Health IT module, MeldRx is sold as a stand-alone module to EHRs to provide a solution for their §170.315 (g)(7), §170.315 (g)(10), and §170.315 (b)(10) criteria for the ONC Certification. The API criteria were tested individually during the ONC certification process. However, in the real world, these certified API modules provide one seamless approach to accomplish the patient/authorized representative’s request for EHI documentation from providers using an ONC Certified EHR. We will test the §170.315 (b)(10) criteria separately. This will cover both single and bulk data requests for all criteria. To that end, the Real World Test plan will be designed to demonstrate how these combined modules perform in the production environment. This certified product is deployed with many EHRs covering multiple specialties within the ambulatory marketplace. We will design our Real World Test plan to reinforce the capabilities that we encounter in these ambulatory use cases. The MeldRx application does allow providers to fully satisfy their reporting requirements for the Promoting Interoperability category of MIPS. 


STANDARDS UPDATES (INCLUDING STANDARDS VERSION ADVANCEMENT PROCESS (SVAP) AND UNITED STATES CORE DATA FOR INTEROPERABILITY (USCDI))

Standard (and version) Standards as specified by the USCDI v1
Updated certification criteria and associated product N/A
Health IT Module CHPL ID N/A
Method used for standard update N/A
Date of ONC-ACB notification N/A
Date of customer notification (SVAP only) N/A
Conformance measure N/A
USCDI-updated certification criteria (and USCDI version) N/A

Measures Used in Overall Approach

DESCRIPTION OF MEASUREMENT/METRIC

The Measure/Metrics and the Descriptions listed below will apply to the simultaneous and seamless use of the functionality of certified measures §170.315 (g)(7) and §170.315 (g)(10). We will independently test the §170.315 (b)(10) criteria. The RWT will be witnessed via a Zoom session with the participants using a production environment and real patient data. Upon completion, certified technology's successful conformance to Authenticate a patient/authorized representative and request portions of the EHI using an application of their choice outside of the EHR’s domain.

Measurement/Metric Description
MEASURE 1: The patient/authorized representative will be able to access (after authentication) partial summary EHI through an API call from a third-party application running on a patient-owned device to the API of the EHR. This same patient/authorized representative will be enabled to present their authenticated credentials to use a third-party application running on a patient-owned device to access partial encounter summary data of their choice, for a given date range. We will demonstrate a single and bulk data request. They will be able to view and or transmit their information as they see fit from the application on their device. This will meet § 170.315 (g)(7 and 10).

ASSOCIATED CERTIFICATION CRITERIA

Measurement/Metric Associated Certification Criteria Relied Upon Software
MEASURE 1 §170.315 (g)(7) and §170.315 (g)(10) N/A
MEASURE 2 §170.315 (b)(10) N/A
 

JUSTIFICATION FOR SELECTED MEASUREMENT/METRIC

Measurement/Metric Justification
MEASURE 1: The patient/authorized representative will be able to access (after authentication) partial summary EHI through an API call from a third-party application running on a patient-owned device to the API of the EHR. The certified EHR technology must allow the patient to obtain portions of their medical information via a request from an application outside of the domain of an EHR for a given date range. This single and bulk data request must be supported. This functionality will supplement the capabilities that are achieved with a patient portal.
MEASURE 2: Export USCDIv1 clinical data for a population of patients for use in a different health information technology product or a third-party system. This export can be used for many purposes, including data portability when a physician's practice switches to a new EHR platform. We chose to concentrate on the aspects of this criterion that would: 1) Demonstrate an EHR's ability to export batches of patient data in a straightforward fashion 2) Facilitate interoperability by providing the exported data in the form of valid C-CDA files that conform to the HL7 standards as described in the HL7 Implementation Guide for CDA® Release 2: Consolidated CDA Templates for Clinical Notes (US Realm). It also includes a publicly accessible hyperlink to the export’s format.
 

CARE SETTING(S)

Care Setting Justification
This plan will test with EHRs in ambulatory settings that range from a single provider to up to 150 providers. The plan will include testing within practices of different specialties to confirm that the type of specialty does not play a role in the data collection. The MeldRx is positioned to be used by providers using EHRs in multiple points of service and multiple specialties. This test plan will demonstrate that the overall functionality is the same regardless of the facility or specialty. We will get feedback from Internal Medicine, Cardiology, Behavioral Health, and Dermatology. Additionally, we will document that the EHR performs the same in different facilities. The overall process will be the same in all specialties. However, we will confirm that the EHR accommodates the specific workflow of each specialty. Real patient data will be deidentified and the testing will be using a production environment. The ability to complete all measures successfully with these practices will be documented by observing the completed tasks. Deviations from the designed process, if any, will be noted and addressed.

EXPECTED OUTCOMES

Measurement/Metric Expected Outcomes
Measure 1:
§170.315 (g)(7) and §170.315 (g)(10)
The Real World Testing will demonstrate that the clinician has the functionality within their EHR to receive a request with sufficient information to uniquely identify a patient and return an ID or other token that can be used by an application to subsequently execute requests for that patient’s data. The EHR will demonstrate the functionality to respond to specific date range requests for patient data (single and bulk) containing partial data categories specified in the USCDI v1 Data Set. This one-time return of such data (according to the specified standards, where applicable) will allow the patient/authorized representative to view and transmit the data as needed on their application on their selected device. The EHR will respond to requests for patient data associated with a specific date and requests for patient data within a specified date range. A 0% error rate is expected.
Measure 2:
§170.315 (b)(10)
• Date and time ranges can be configurable via the UI
• Targeted Practices can be configurable via the UI
• Patients exported can be configurable via the UI
• Logging in as a Vendor Admin will allow access to the export functionality
• Logging in as a non-Vendor Admin will not allow access to the export functionality
• Use the Edge Test Tool to check the validity of the output file
• Data was available for the entered date and time range
• The export summary contained data only within that date and time range
• Export summary was created and completed successfully
• Saving to a preferred location is allowed
• Visually confirming the export after the save is performed and successful
• Prepare RWT results report with 95% plus success rate
 

SCHEDULE OF KEY MILESTONES

Key Milestone Care Setting Date/Timeframe
Prepare the MeldRx application to collect data upon request by patients/authorized representatives Ambulatory Setting and Multiple Specialties December 2024
Identify the user practices that will participate in the test plan Ambulatory Setting and Multiple Specialties December 2024 & January 2025
Confirm that the Real World Test Plan participants can log into their accounts and are ready to demonstrate the request and response for the patient EHI Ambulatory Setting and Multiple Specialties January 2025
Follow up with the Real World Test Plan participants regularly (minimum, once a quarter) to obtain feedback on their progress and address any issues Ambulatory Setting and Multiple Specialties Quarterly 2025
End the Real World Test to coincide with the end of the 2025 Calendar Year Ambulatory Setting and Multiple Specialties December 2025
Real World Test analysis and report generation Ambulatory Setting and Multiple Specialties January 2026
Submit Real World Test Report to ACB before the established deadline Ambulatory Setting and Multiple Specialties January 2026
 

Attestation

This Real World Testing plan includes all required elements, including measures that address all certification criteria and care settings. All the information in this plan is current and comprehensively addresses the health IT developer’s Real World Testing requirements.

Authorized Representative Name: Wayne Singer

Authorized Representative Email: wayne@darenasolutions.com

Authorized Representative Phone: 832-736-2552

Authorized Representative Signature: /Wayne Singer/

Date: 10/28/2024


Interested in Utilizing MeldRx’s ONC Certified Criteria?